1 / 71

EMS Vaccine Project

EMS Vaccine Project. New Hampshire Division of Fire Standards and Training and Emergency Medical Services. http://dannymiller.typepad.com/blog/images/epidemic.jpg. Acknowledgments. Developed under the CDC Preparedness Grant Dr. Joseph Sabato Paramedic Chuck Hemeon

pia
Download Presentation

EMS Vaccine Project

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EMS Vaccine Project New Hampshire Division of Fire Standards and Training and Emergency Medical Services http://dannymiller.typepad.com/blog/images/epidemic.jpg

  2. Acknowledgments • Developed under the CDC Preparedness Grant • Dr. Joseph Sabato • Paramedic Chuck Hemeon • Paramedic Vicki Blanchard • Paramedic/RN Clay Odell • Bureau Chief Sue Prentiss

  3. Acknowledgments • This EMS Vaccine Program has been partly funded under an Agreement with the State of NH, Dept. of Health & Human Services, by the US Dept. of HHS • the Office of the Assistant Secretary for Preparedness and Response - the Hospital Preparedness Program.

  4. Why are we here? • Diseases of greatest concern • CDC Guidelines and Federal Laws • Federally required documentation • How to assist State Health Officials • Not here for lessons on IM injections

  5. Public health principles relative to infectious (communicable) diseases • Human populations • Demographic characteristics • Infectious disease dynamics • Population variations

  6. Worldwide Deaths

  7. Infectious Disease Mortality in the USA 1900 to 1996

  8. Epidemic http://isiria.files.wordpress.com/2009/03/epidemic-nml.jpg

  9. Pandemic http://www.zmangames.com/boardgames/files/pandemic/NotfinalPandemic_board.jpg

  10. Influenza • “The Flu”: a highly contagious viral infection of the nose, throat and lungs • Influenza is an RNA virus • Type A & B • Respiratory symptoms, causing epidemics • Type C • Mild, do not cause symptoms

  11. www.abc.net.au/health/library/influenza_ff.htm Type A • Hemagglutinin (H) • Neuraminidase (N) • These two proteins determine immunity, infection, severity and diagnosis of flu • Also infects horses, pigs, birds

  12. Influenza Concerns • The influenza Type A viruses that are presently infecting humankind are: • A(H1N1) or "Spanish Flu“ • A(H1N1) or “Swine Flu” • A(H3N2)- or "Hong Kong Flu". • A(H1N2) a re-assortment of the above

  13. Influenza Pandemic History • 1918 Spanish Flu • 1957 Asian Flu • 1968 Hong Kong Flu • 1997 Avian Flu • 2009 Swine Flu

  14. 1918 Spanish Flu A(H1N1) • Summer-Fall 1918 • AKA Spanish Flu • World War I • Influenza 1918 - 1919 • 20 million to 50 million deaths worldwide • 675,000 deaths in USA • Undiscovered virus at the time • Mass casualty in health facilities

  15. 1918 Pandemic – Deaths per 1,000

  16. 1957 Asian Flu A(H2N2) • 1 – 2 million deaths worldwide • 70,000 USA deaths • Contraction rates greatest among school age • Death rates were highest among elderly • Science and technology advancement enabled vaccine

  17. 1968 Hong Kong Flu A(H2N2) • 700,000 deaths worldwide (34,000 USA) • Fewer people died because: • Improved medical care supported very ill • Antibiotics now available for secondary illnesses • Antigen N2 same as with 1957 Asian flu, severity probably reduced because people retained antibodies against N2 in their system from the 1957 pandemic

  18. 1997 Avian Influenza A(H5N1) • Avian (bird) influenza (flu) • Occurs naturally among birds • Infection can occur in humans • Most human infection result from contact with infected poultry or surfaces contaminated with secretion/excretions from infected birds • Very rarely spread from one ill person to another

  19. Bird Flu (Avian Flu)1997 - 2009 • Slaughter of chickens occurred to removed source of infection to humans • World Health Organization (WHO) keeps surveillance on the Avian Flu • www.who.int/en/ for the most up to date information • Since June 2, 2009: 433 cases with 262 deaths from Avian Flu

  20. Great Reading

  21. Influenza Vaccine • Vaccine comes in two forms • inactivated virus for intramuscular administration • Live, antennuated virus for intranasal administration

  22. Influenza Vaccine

  23. Manufactured in eggs Takes six months to manufacture adequate vaccine Patient’s allergic to eggs should not receive the vaccine. Manufactured in eggs

  24. Influenza Vaccine • Most effective if given within 2-4 months of illness • 90% effective in preventing illness in the healthy • 50-60% effective at preventing hospitalization in elderly • 80% effective at preventing death

  25. Principals Vaccination • Active immunity produced by vaccine • Immunity similar to natural infection but without risk of disease

  26. Live Attenuated Vaccine • Pathogen grown in animal or tissue culture under conditions that make it less virulent. • Nasal Spray Form

  27. Influenza Clinical Features • Incubation period 2 days (range 1-5 days) • Severity of illness depends on prior experience with related variants • Abrupt onset of fever, myalgia, sore throat, nonproductive cough, headache

  28. Influenza Complications • Pneumonia • secondary bacterial • primary influenza viral • Reye syndrome • Myocarditis • Death 0.5 -1 per 1,000 cases

  29. Healthcare Flu Vaccination • Historic rates of 34% for healthcare workers • Leading cause of occupational illness and risk of spread to patients • In pandemic planning we need to increase

  30. Protection for yourself & your EMS crew • Infection control policies & procedures • Proper respiratory protection • N-95 or HEPA filter mask • Fit-tested • Hand-hygiene policies • Cleaning of ambulance, stretcher and equipment

  31. Influenza Vaccine Indications • Children > 6 month to 5 years • Pregnant women • Adults greater then 50 years of age • Healthcare workers • Patients with history of chronic diseases • Patient with immunocompromise

  32. Influenza Vaccine Contraindications • Influenza vaccine is not approved for children < 6 months of age • Allergy to eggs, vaccine or thimerosal • Moderate to severe acute illness with fever • Previous adverse reaction • History of Guillain-Barre syndrome within 6 weeks of previous influenza vaccines

  33. Influenza Vaccine (Injection)Side effects • The viruses in the flu shot are killed (inactive), so you CANNOT get the flu from the flu shot (CDC) • Soreness, redness or swelling where the shot was given • Fever (low grade) • Malaise

  34. Influenza Vaccine Live Attenuated (Nasal-Spray) Side Effects • Per the CDC “The viruses in the nasal-spray vaccine are weakened and do not cause severe symptoms often associated with influenza illness. (In clinical studies, transmission of vaccine viruses to close contacts has occurred only rarely.) • Children: runny nose, headache, vomiting, malaise, fever • Adults: runny nose, headache, sore throat, cough

  35. Influenza Vaccine Dose (Injection) • 0.5ml intramuscular injection in the deltoid with a 1 -1 1/2 inch 22-25 gauge needle

  36. Pneumococcal Pneumonia • Common but serious pulmonary infection • The gram-positive, spherical bacteria, Streptococcus pneumoniae • Elderly, infants, cancer patients, AIDS patients, post-operative, alcoholics and diabetics at highest risk • CDC states the only way to prevent is with pneumococcal vaccine

  37. An Ounce of Prevention • During the past decade many strains of pneumococcus have become resistant to antibiotics • Vaccination prevents contracting the disease

  38. Polysaccharide Vaccines • Made from the sugar coating of the bacteria • Mediated by antibodies • Exposing the person to only part of the bacterium elicits a protective active immune response

  39. Pneumococcal Polysaccharide Vaccine • The polysaccharide coating doesn’t mutate or change very often • There are only 23 subtypes • Vaccination lasts about 10 years • Reduces complications from pneumonia

  40. Pneumococcal Polysaccharide Vaccine Indications • People over 65 years of age • Children over 2 years of age with chronic illness

  41. Pneumococcal Polysaccharide Vaccine Contraindications • Allergy • Moderate to severe illness

  42. Pneumococcal Polysaccharide Vaccine Side events • Local reaction • Myalgia and fever

  43. Pneumococcal Vaccine Dose • 0.5ml intramuscular injection in the deltoid with a 1 -11/2 inch 22-25 gauge needle • Children receive a series of 4 shots with a different vaccine • Children with special needs should be referred to their pediatrician or medical specialist

  44. Severe Adult Respiratory Syndrome (SARS) • Newly identified acute viral respiratory syndrome • Caused by a novel coronavirus (not Corona beer) • Corona means crown-like (under microscope the SAR-CoV looks crown-like) • 2002 – 2003 Epidemic involving 26 countries with 8098 cases and 774 death.

  45. So why are we here?

  46. NH Immunization Protocol 5.15

  47. Required forms/documents • Its Federal Law • Screening Questionnaire • Do I Need a Vaccine Today? • Vaccine Information Sheets (VIS) • Vaccine Administration Record • Skills Checklist for Immunization

  48. Vaccine Administration Procedure • Reference Appendix CDC Immunization Guide • CDCs “Pink Book” Epidemiology and Prevention of Vaccine-Preventable Diseases

  49. It’s Federal Law!

More Related